can glp 1 cause insulin resistance GLP-1 Receptor Agonists as Treatments for Type 2 Diabetes Cardiovascular effects of Glucagon-like peptide

Glucagon-like peptide receptor agonists (GLP-1 RAs) now available to promote weight lossWegovy (semaglutide), Zepbound (tirzepatide), and Saxenda (liraglutide)could potentially make much needed gains against the obesity epidemic

What concerns me most is the amount of misinformation being spread by individuals who have never prescribed these medications, never followed patients longitudinally, and often rely on fear rather than evidence

And eventually, it may be evidence payers, clinicians, employers, and patients all start asking for.

doi: 10.1177/15593258231200527

Indias drug regulator steps up action against unauthorised sale and promotion of GLP-1 weight-loss drugs, warning of health risks and tightening inspections across pharmacies and online platforms.

While drugmakers and their sockpuppet groups continue their attempt to weaponize fear and misinformation to protect market share, we think Scott clearly articulated the reality of the situation: Compounding pharmacies have prioritized patient needs